Skip to main content
Download PDF
  • Review
  • Published:

Laminopathies: The molecular background of the disease and the prospects for its treatment

Cellular & Molecular Biology Letters volume 16, pages 114–148 (2011)Cite this article

Abstract

Laminopathies are rare human degenerative disorders with a wide spectrum of clinical phenotypes, associated with defects in the main protein components of the nuclear envelope, mostly in the lamins. They include systemic disorders and tissue-restricted diseases. Scientists have been trying to explain the pathogenesis of laminopathies and find an efficient method for treatment for many years. In this review, we discuss the current state of knowledge about laminopathies, the molecular mechanisms behind the development of particular phenotypes, and the prospects for stem cell and/or gene therapy treatments.

Abbreviations

ADLD:

adult-onset autosomal dominant leukodystrophy

APL:

acquired partial lipodystrophy

CMD1A:

dilated cardiomyopathy 1A with conduction defect

CMT2B1:

Charcot-Marie-Tooth disease type 2B1

DMD:

Duchenne muscular dystrophy

EDMD:

autosomal dominant Emery-Dreifuss muscular dystrophy

ERK:

extracellular signal-regulated kinase

GL:

generalized lipodystrophy

FPLD:

Dunnigan familial partial lipodystrophy

HGPS:

Hutchinson Gilford progeria syndrome

INM:

inner nuclear membrane

JNK:

c-Jun NH(2)-terminal kinase

LAP:

lamina-associated polypeptide

LBR:

p58 protein, lamin B receptor, 3 beta-hydroxysterol D14-reductase

LGMDB1:

limb-girdle muscular dystrophy type 1B

LINC:

linker of the nucleoskeleton and cytoskeleton

LMNA :

gene encoding A/C type lamins

MAD:

mandibuloacral dysplasia

NE:

nuclear envelope

PPARγ:

peroxisome proliferator-activated receptor γ

pRB:

retinoblastoma protein

ZMPSTE24/FACE1:

zinc metalloproteinase STE 24 homology

References

  1. Worman, H.J., Fong, L.G., Muchir, A. and Young, S.G. Laminopathies and the long strange trip from basic cell biology to therapy. J. Clin. Invest. 119 (2009) 1825–1836.

    Article  CAS  PubMed  Google Scholar 

  2. Worman, H.J., Fong, L.G., Muchir, A. and Young, S.G. The nuclear envelope from basic biology to therapy. Biochem. Soc. Trans. 38 (2010) 253–256.

    Article  CAS  PubMed  Google Scholar 

  3. Foster, C.R., Przyborski, S.A., Wilson, R.G. and Hutchison, C.J. Lamins as cancer biomarkers. Biochem. Soc. Trans. 38 (2010) 297–300.

    Article  CAS  PubMed  Google Scholar 

  4. Hetzer, M.W. The Nuclear Envelope. Cold Spring Harb. Perspect Biol. (2010) cshperspect.a000539.

  5. Rzepecki, R., Smithe, C. and Hutchison, C.J. The role of mitotic vesicles in the nuclear assembly. Cell. Mol. Biol. Lett. 7 (2002) 299.

    PubMed  Google Scholar 

  6. Herrmann, H., Bar, H., Kreplak, L., Strelkov, S.V. and Aebi, U. Intermediate filaments: from cell architecture to nanomechanics. Nat. Rev. Mol. Cell Biol. 8 (2007) 562–573.

    Article  CAS  PubMed  Google Scholar 

  7. Dechat, T., Pfleghaar, K., Sengupta, K., Shimi, T., Shumaker, D.K., Solimando, L. and Goldman, R.D. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev. 22 (2008) 832–853.

    Article  CAS  PubMed  Google Scholar 

  8. Liu, Q., Kim, D.I., Syme, J., LuValle, P., Burke, B. and Roux, K.J. Dynamics of lamin-A processing following precursor accumulation. PLoS One 5 (2010) e10874.

    Article  PubMed  CAS  Google Scholar 

  9. Prokocimer, M., Davidovich, M., Nissim-Rafinia, M., Wiesel-Motiuk, N., Bar, D., Barkan, R., Meshorer, E. and Gruenbaum, Y. Nuclear lamins: key regulators of nuclear structure and activities. J. Cell. Mol. Med. 13 (2009) 1059–1085.

    Article  CAS  PubMed  Google Scholar 

  10. Zaremba-Czogalla, M., Dubińska-Magiera, M. and Rzepecki, R. [Nowe funkcje lamin — starzy znajomi w nowym świetle]. Postępy Biologii Komórki 37 (2010) 1–18.

    Google Scholar 

  11. Bonne, G., Di Barletta, M.R., Varnous, S., Becane, H.M., Hammouda, H.E., Merlini, L., Muntoni, F., Greenberg, C.R., Gary, F., Urtizberea, J.A., Duboc, D., Fardeau, M., Toniolo, D. and Schwartz, K. Mutations in the gene encoding laminA/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nature Genet. 21 (1999) 285–288.

    Article  CAS  PubMed  Google Scholar 

  12. Di Barletta, M., Ricci, E., Galluzzi, G., Tonali, P., Mora, M., Morandi, L., Romorini, A., Voit, T., Orstavik, K.H. and Merlini, L. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 66 (2000) 1407–1412.

    Article  Google Scholar 

  13. Muchir, A., Bonne, G., van der Kooi, A.J., van Meegen, M., Baas, F., Bolhuis, P.A., de Visser, M. and Schwartz, K. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 9 (2000) 1453–1459.

    Article  CAS  PubMed  Google Scholar 

  14. Fatkin, D., MacRae, C., Sasaki, T., Wolff, M.R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H.J., Spudich, S., De Girolami, U., Seidman, J.G., Seidman, C., Muntoni, F., Muehle, G., Johson, W. and McDonough, B. Missense mutations in the rod domain in the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. New Eng. J. Med. 341 (1999) 1715–1724.

    Article  CAS  PubMed  Google Scholar 

  15. Bione, S., Maestrini, E., Rivella, S., Mancini, M., Regis, S., Romeo, G. and Toniolo, D. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat. Genet. 8 (1994) 323–327.

    Article  CAS  PubMed  Google Scholar 

  16. Renou, L., Stora, S., Yaou, R.B., Volk, M., Sinkovec, M., Demay, L., Richard, P., Peterlin, B. and Bonne, G. Heart-hand syndrome of Slovenian type: a new kind of laminopathy. J. Med. Genet. 45 (2008) 666–671.

    Article  CAS  PubMed  Google Scholar 

  17. Cao, H. and Hegele, R.A. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9 (2000) 109–112.

    Article  CAS  PubMed  Google Scholar 

  18. Drac, H., Madej-Pilarczyk, A., Gospodarczyk-Szot, K., Gaweł, M., Kwieciński, H. and Hausmanowa-Petrusewicz, I. Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G>A (Arg482Gln) in a Polish family. Neurol. Neurochir. Pol. 44 (2010) 291–296.

    PubMed  Google Scholar 

  19. Hegele, R.A., Cao, H., Liu, D.M., Costain, G.A., Charlton-Menys, V., Rodger, N.W. and Durrington, P.N. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am. J. Hum. Genet. 79 (2006) 383–389.

    Article  CAS  PubMed  Google Scholar 

  20. Young, J., Morbois-Trabut, L., Couzinet, B., Lascols, O., Dion, E., Bereziat, V., Feve, B., Richard, I., Capeau, J., Chanson, P. and Vigouroux, C. Type A insulin resistance syndrome revealing a novel lamin A mutation. Diabetes 54 (2005) 1873–1878.

    Article  CAS  PubMed  Google Scholar 

  21. De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C.L., Munnich, A., Le Merrer, M. and Levy, N. Lamin a truncation in Hutchinson-Gilford progeria. Science 300 (2003) 2055.

    Article  PubMed  Google Scholar 

  22. Chen, L., Lee, L., Kudlow, B., Dos Santos, H., Sletvold, O., Shafeghati, Y., Botha, E., Garg, A., Hanson, N., Martin, G.M., Mian, I.S., Kennedy, B.K. and Oshima, J. LMNA mutations in atypical Werner’s syndrome. Lancet 362 (2003) 440–445.

    Article  CAS  PubMed  Google Scholar 

  23. Navarro, C.L., Cadinanos, J., De Sandre-Giovannoli, A., Bernard, R., Courrier, S., Boccaccio, I., Boyer, A., Kleijer, W.J., Wagner, A., Giuliano, F., Beemer, F.A., Freije, J.M., Cau, P., Hennekam, R.C., Lopez-Otin, C., Badens, C. and Levy, N. Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum. Mol. Genet. 14 (2005) 1503–1513.

    Article  CAS  PubMed  Google Scholar 

  24. Agarwal, A.K., Fryns, J.P., Auchus, R.J. and Garg, A. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum. Mol. Genet. 12 (2003) 1995–2001.

    Article  CAS  PubMed  Google Scholar 

  25. Novelli, G., Muchir, A., Sangiuolo, F., Helbling-Leclerc, A., D’Apice, M.R., Massart, C., Capon, F., Sbraccia, P., Federici, M., Lauro, R., Tudisco, C., Pallotta, R., Scarano, G., Dallapiccola, B., Merlini, L. and Bonne, G. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 71 (2002) 426–431.

    Article  CAS  PubMed  Google Scholar 

  26. Hoffmann, K., Dreger, C.K., Olins, A.L., Olins, D.E., Shultz, L.D., Lucke, B., Karl, H., Kaps, R., Muller, D., Vaya, A., Aznar, J., Ware, R.E., Cruz, N.S., Lindner, T.H., Herrmann, H., Reis, A. and Sperling, K. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huet anomaly). Nat. Genet. 31 (2002) 410–414.

    CAS  PubMed  Google Scholar 

  27. Garg, A., Subramanyam, L., Agarwal, A.K., Simha, V., Levine, B., D’Apice, M.R., Novelli, G. and Crow, Y. Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J. Clin. Endocrinol. Metab. 94 (2009) 4971–4983.

    Article  CAS  PubMed  Google Scholar 

  28. De Sandre-Giovannoli, A., Chaouch, M., Kozlov, S., Vallat, J.M., Tazir, M., Kassouri, N., Szepetowski, P., Hammadouche, T., Vandenberghe, A., Stewart, C.L., Grid, D. and Levy, N. Homozygous defects in LMNA, encoding lamin A/C nuclear envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 70 (2002) 726–736.

    Article  PubMed  Google Scholar 

  29. Padiath, Q.S., Saigoh, K., Schiffmann, R., Asahara, H., Yamada, T., Koeppen, A., Hogan, K., Ptacek, L.J. and Fu, Y.H. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat. Genet. 38 (2006) 1114–1123.

    Article  CAS  PubMed  Google Scholar 

  30. Vantyghem, M.C., Pigny, P., Maurage, C.A., Rouaix-Emery, N., Stojkovic, T., Cuisset, J.M., Millaire, A., Lascols, O., Vermersch, P., Wemeau, J.L., Capeau, J. and Vigouroux, C. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. J. Clin. Endocrinol. Metab. (2004) 5337–5346.

  31. Vantyghem, M.C., Faivre-Defrance, F., Marcelli-Tourvieille, S., Fermon, C., Evrard, A., Bourdelle-Hego, M.F., Vigouroux, C., Defebvre, L., Delemer, B. and Wemeau, J.L. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism. Clin. Endocrinol (Oxf). 67 (2007) 247–249.

    Article  CAS  Google Scholar 

  32. Benedetti, S., Bertini, E., Iannaccone, S., Angelini, C., Trisciani, M., Toniolo, D., Sferrazza, B., Carrera, P., Comi, G., Ferrari, M., Quattrini, A. and Previtali, S.C. Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1019–1021.

    Article  CAS  PubMed  Google Scholar 

  33. Goizet, C., Yaou, R., Demay, L., Richard, P., Bouillot, S., Rouanet, M., Hermosilla, E., Le Masson, G., Lagueny, A., Bonne, G. and Ferrer, X. A new mutation of the lamin A/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia. J. Med. Genet. 41 (2004) e29.

    Article  CAS  PubMed  Google Scholar 

  34. Hegele, R.A. and Oshima, J. Phenomics and lamins: from disease to therapy. Exp. Cell Res. 313 (2007) 2134–2143.

    Article  CAS  PubMed  Google Scholar 

  35. Harborth, J., Elbashir, S.M., Bechert, K., Tuschl, T. and Weber, K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114 (2001) 4557–4565.

    CAS  PubMed  Google Scholar 

  36. Vergnes, L., Peterfy, M., Bergo, M.O., Young, S.G. and Reue, K. Lamin B1 is required for mouse development and nuclear integrity. Proc. Natl. Acad. Sci. USA 101 (2004) 10428–10433.

    Article  CAS  PubMed  Google Scholar 

  37. Coffinier, C., Chang, S.Y., Nobumori, C., Tu, Y., Farber, E.A., Toth, J.I., Fong, L.G. and Young, S.G. Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency. Proc. Natl. Acad. Sci. USA 107 (2010) 5076–5081.

    Article  CAS  PubMed  Google Scholar 

  38. Waterham, H.R., Koster, J., Mooyer, P., van Noort, G., Kelley, R.I., Wilcox, W.R., Wanders, R.J.A., Hennekam, R.C.M. and Oosterwijk, J.C. Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3betahydroxysterol delta14-reductase deficiency due to mutations in the lamin B receptor gene. Am. J. Hum. Genet. 72 (2003) 1013–1017.

    Article  CAS  PubMed  Google Scholar 

  39. Yuste-Chaves, M., Cañueto, J., Santos-Briz, A., Ciria, S., González-Sarmiento, R. and Unamuno, P. Buschke-Ollendorff Syndrome with Striking Phenotypic Variation Resulting from a Novel c.2203C>T Nonsense Mutation in LEMD3. Pediatr. Dermatol. (2010) DOI: 10.1111/j.1525-1470.2010

  40. Taylor, M.R., Slavov, D., Gajewski, A., Vlcek, S., Ku, L., Fain, P.R., Carniel, E., Di Lenarda, A., Sinagra, G., Boucek, M.M., Cavanaugh, J., Graw, S.L., Ruegg, P., Feiger, J., Zhu, X., Ferguson, D.A., Bristow, M.R., Gotzmann, J., Foisner, R. and Mestroni, L. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum. Mutat. 26 (2005) 566–574.

    Article  CAS  PubMed  Google Scholar 

  41. Landires, I., Pascale, J.M. and Motta, J. The position of the mutation within the LMNA gene determines the type and extent of tissue involvement in laminopathies. Clin. Genet. 71 (2007) 592–593.

    Article  CAS  PubMed  Google Scholar 

  42. Scharner, J., Gnocchi, V.F., Ellis, J.A. and Zammit, P.S. Genotypephenotype correlations in laminopathies: how does fate translate? BMC Dev. Biol. 38 (2010) 257–262.

    CAS  Google Scholar 

  43. Simon, D.N., Zastrow, M.S. and Wilson, K.L. Direct actin binding to A- and B-type lamin tails and actin filament bundling by the lamin A tail. Nucleus 1 (2010) 264–272.

    Google Scholar 

  44. Magracheva, E., Kozlov, S., Stewart, C.L., Wlodawer, A. and Zdanov, A. Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD). Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 65 (2009) 665–670.

    Article  CAS  Google Scholar 

  45. Sewry, C. Muscular dystrophies: an update on pathology and diagnosis. Acta Neuropathol. 120 (2010) 343–358.

    Article  CAS  PubMed  Google Scholar 

  46. Rzepecki, R. The nuclear lamins and nuclear envelope. Cel. Mol. Biol. Lett. 7 (2002) 1019–1035.

    CAS  Google Scholar 

  47. Chmielewska, M., Dubińska-Magiera, M., Sopel, M., Rzepecka, D., Hutchison, C.J., Goldberg, M.W. and Rzepecki, R. Embryonic and adult isoforms of XLAP2 form microdomains associated with chromatin and the nuclear envelope. Cell Tissue Res. (2011), in press.

  48. Margalit, A., Brachner, A., Gotzmann, J., Foisner, R. and Gruenbaum, Y. Barrier-to-autointegration factor—a BAFfling little protein. Trends Cell Biol. 17 (2007) 202–208.

    Article  CAS  PubMed  Google Scholar 

  49. Emery, A.E. and Dreifuss, F.E. Unusual type of benign X-linked muscular dystrophy. J. Neurol. Neurosurg. Psychiatry 29 (1966) 338–342.

    Article  CAS  PubMed  Google Scholar 

  50. Vaughan, O.A., Alvarez-Reyes, M., Bridger, J.M., Broers, J.L.V., Ramaekers, F.C.S., Wehnert, M., Morris, G.E., Whitfield, W.G.F. and Hutchison, C.J. Both emerin and lamin C depend on lamin A for localization at the nuclear envelope. J. Cell Sci. 114 (2001) 2577–2590.

    CAS  PubMed  Google Scholar 

  51. Wheeler, M.A. and Ellis, J.A. Molecular signatures of Emery-Dreifuss muscular dystrophy. Biochem. Soc. Trans. 36 (2008) 1354–1358.

    Article  CAS  PubMed  Google Scholar 

  52. Gueneau, L., Bertrand, A.T., Jais, J.P., Salih, M.A., Stojkovic, T., Wehnert, M., Hoeltzenbein, M., Spuler, S., Saitoh, S., Verschueren, A., Tranchant, C., Beuvin, M., Lacene, E., Romero, N.B., Heath, S., Zelenika, D., Voit, T., Eymard, B., Ben Yaou, R. and Bonne, G. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 85 (2009) 338–353.

    Article  CAS  PubMed  Google Scholar 

  53. Zhang, Q., Bethmann, C., Worth, N.F., Davies, J.D., Wasner, C., Feuer, A., Ragnauth, C.D., Yi, Q., Mellad, J.A., Warren, D.T., Wheeler, M.A., Ellis, J.A., Skepper, J.N., Vorgerd, M., Schlotter-Weigel, B., Weissberg, P.L., Roberts, R.G., Wehnert, M. and Shanahan, C.M. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum. Mol. Genet. 16 (2007) 2816–2833.

    Article  CAS  PubMed  Google Scholar 

  54. Taylor, M.R.G., Fain, P.R., Sinagra, G., Robinson, M.L., Robertson, A.D., Carniel, E., Di Lenarda, A., Bohlmeyer, T.J., Ferguson, D.A., Brodsky, G.L., Boucek, M.M., Lascor, J., Moss, A.C., Li, W.-L.P., Stetler, G.L., Muntoni, F., Bristow, M.R., Mestroni, L. and Group, F.D.C.R.R. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J. Am. Coll. Cardiol. 41 (2003) 771–780.

    Article  CAS  PubMed  Google Scholar 

  55. Arbustini, E., Pilotto, A., Repetto, A., Grasso, M., Negri, A., Diegoli, M., Campana, C., Scelsi, L., Baldini, E., Gavazzi, A. and Tavazzi, L. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J. Am. Coll. Cardiol. 39 (2002) 981–990.

    Article  CAS  PubMed  Google Scholar 

  56. Muchir, A. and Worman, H.J. Emery-Dreifuss muscular dystrophy. Curr. Neurol. Neurosci. Rep. 7 (2007) 78–83.

    Article  CAS  PubMed  Google Scholar 

  57. Quijano-Roy, S., Mbieleu, B., Bönnemann, C.G., Jeannet, P.Y., Colomer, J., Clarke, N.F., Cuisset, J.M., Roper, H., De Meirleir, L., D’Amico, A., Ben Yaou, R., Nascimento, A., Barois, A., Demay, L., Bertini, E., Ferreiro, A., Sewry, C.A., Romero, N.B., Ryan, M., Muntoni, F., Guicheney, P., Richard, P., Bonne, G. and Estournet, B. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann. Neurol. 64 (2008) 177–186.

    Article  PubMed  Google Scholar 

  58. Dahl, K.N., Booth-Gauthier, E.A. and Ladoux, B. In the middle of it all: mutual mechanical regulation between the nucleus and the cytoskeleton. J. Biomech. 43 (2010) 2–8.

    Article  PubMed  Google Scholar 

  59. Attali, R., Warwar, N., Israel, A., Gurt, I., McNally, E., Puckelwartz, M., Glick, B., Nevo, Y., Ben-Neriah, Z. and Melki, J. Mutation of SYNE-1, encoding an essential component of the nuclear lamina, is responsible for autosomal recessive arthrogryposis. Hum. Mol. Genet. 18 (2009) 3462–3469.

    Article  CAS  PubMed  Google Scholar 

  60. Gros-Louis, F., Dupré, N., Dion, P., Fox, M.A., Laurent, S., Verreault, S., Sanes, J.R., Bouchard, J.P. and Rouleau, G.A. Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat. Genet. 39 (2007) 80–85.

    Article  CAS  PubMed  Google Scholar 

  61. Holaska, J.M. and Wilson, K.L. An emerin “proteome”: purification of distinct emerincontaining complexes from HeLa cells suggests molecular basis for diverse rolesincluding gene regulation, mRNA splicing, signaling, mechanosensing, and nu clear architecture. Biochemistry 46 (2007) 8897–8908.

    Article  CAS  PubMed  Google Scholar 

  62. Andrés, V. and González, J.M. Role of A-type lamins in signaling, transcription, and chromatin organization. J. Cell Biol. 187 (2009) 945–957.

    Article  PubMed  CAS  Google Scholar 

  63. Marmiroli, S., Bertacchini, J., Beretti, F., Cenni, V., Guida, M., De Pol, A., Maraldi, N.M. and Lattanzi, G. A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward. J. Cell. Physiol. 220 (2009) 553–561.

    Article  CAS  PubMed  Google Scholar 

  64. Kim, E.K. and Choi, E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 1802 (2010) 396–405.

    CAS  PubMed  Google Scholar 

  65. González, J.M., Navarro-Puche, A., Casar, B., Crespo, P. and Andrés, V. Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J. Cell Biol. 183 (2008) 653–666.

    Article  PubMed  CAS  Google Scholar 

  66. Muchir, A., Pavlidis, P., Bonne, G., Hayashi, Y.K. and Worman, H.J. Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy. Hum. Mol. Genet. 16 (2007) 1884–1895.

    Article  CAS  PubMed  Google Scholar 

  67. Muchir, A., Pavlidis, P., Decostre, V., Herron, A.J., Arimura, T., Bonne, G. and Worman, H.J. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J. Clin. Invest. 117 (2007) 1282–1293.

    Article  CAS  PubMed  Google Scholar 

  68. Muchir, A., Wu, W. and Worman, H.J. Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells. Biochim. Biophys. Acta 1792 (2009) 75–81.

    CAS  PubMed  Google Scholar 

  69. Emerson, L.J., Holt, M.R., Wheeler, M.A., Wehnert, M., Parsons, M. and Ellis, J.A. Defects in cell spreading and ERK1/2 activation in fibroblasts with lamin A/C mutations. Biochim. Biophys. Acta 1792 (2009) 810–821.

    CAS  PubMed  Google Scholar 

  70. Muchir, A., Shan, J., Bonne, G., Lehnart, S.E. and Worman, H.J. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum. Mol. Genet. 18 (2009) 241–247.

    Article  CAS  PubMed  Google Scholar 

  71. Wu, W., Shan, J., Bonne, G., Worman, H.J. and Muchir, A. Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene. Biochim. Biophys. Acta 1802 (2010) 632–638.

    CAS  PubMed  Google Scholar 

  72. MacDonald, B.T., Tamai, K. and He, X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17 (2009) 9–26.

    Article  CAS  PubMed  Google Scholar 

  73. Markiewicz, E., Tilgner, k., Barker, N., van de Wetering, M., Clevers, H., Dorobek, M., Hausmanowa-Petrusewicz, I., Ramaekers, F.C., Broers, J.L., Blankesteijn, W.M., Salpingidou, G., Wilson, R.G., Ellis, J.A. and Hutchison, C.J. The inner nuclear membrane protein emerin regulates betacatenin activity by restricting its accumulation in the nucleus. EMBO J. 25 (2006) 3275–3285.

    Article  CAS  PubMed  Google Scholar 

  74. Hoppler, S. and Kavanagh, C.L. Wnt signalling: variety at the core. J. Cell Sci. 120 (2007) 385–393.

    Article  CAS  PubMed  Google Scholar 

  75. Goichberg, P., Shtutman, M., Ben-Zeev, A. and Geiger, B. Recruitment of β-catenin to cadherin-mediated intercellular adhesions is involved in myogenic induction. J. Cell Sci. 114 (2001) 1309–1319.

    CAS  PubMed  Google Scholar 

  76. Perez-Ruiz, A., Ono, Y., Gnocchi, V.F. and Zammit, P.S. β-catenin promotes self-renewal of skeletal-muscle satellite cells J. Cell Sci. 121 (2008) 1373–1382.

    Article  CAS  PubMed  Google Scholar 

  77. Hutchison, C.J. and Worman, H.J. A-type lamins: Guardians of the soma? Nat. Cell Biol. 6 (2004) 1062–1067.

    Article  CAS  PubMed  Google Scholar 

  78. Johnson, B.R. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc. Natl. Acad. Sci. USA 101 (2004) 9677–9682.

    Article  CAS  PubMed  Google Scholar 

  79. Markiewicz, E., Dechat, T., Foisner, R., Quinlan, R.A. and Hutchison, C.J. Lamin A/C binding protein LAP2 alpha is required for nuclear anchorage of retinoblastoma protein. Mol. Biol. Cell. 13 (2002) 4401–4413.

    Article  CAS  PubMed  Google Scholar 

  80. Frock, R.L., Kudlow, B.A., Evans, A.M., Jameson, S.A., Hauschka, S.D. and Kennedy, B.K. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev. 20 (2006) 486–500.

    Article  CAS  PubMed  Google Scholar 

  81. Naetar, N. and Foisner, R. Lamin complexes in the nuclear interior control progenitor cell proliferation and tissue homeostasis. Cell Cycle 8 (2009) 1488–1493.

    Article  CAS  PubMed  Google Scholar 

  82. Massagué, J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1 (2000) 169–178.

    Article  PubMed  Google Scholar 

  83. Van Berlo, J.H., Voncken, J.W., Kubben, N., Broers, J.L., Duisters, R., van Leeuwen, R.E., Crijns, H.J., Ramaekers, F.C., Hutchison, C.J. and Pinto, Y.M. A-type lamins are essential for TGF-ta1 induced PP2A to dephosphorylate transcription factors. Hum. Mol. Genet. 14 (2005) 2839–2849.

  84. Puri, P.L., Iezzi, S., Stiegler, P., Chen, T.T., Schiltz, R.L., Muscat, G.E., Giordano, A., Kedes, L., Wang, J.Y. and Sartorelli, V. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol. Cell. 8 (2001) 885–897.

    Article  CAS  PubMed  Google Scholar 

  85. Park, Y.E., Hayashi, Y.K., Goto, K., Komaki, H., Hayashi, Y., Inuzuka, T., Noguchi, S., Nonaka, I. and Nishino, I. Nuclear changes in skeletal muscle extend to satellite cells in autosomal dominant Emery-Dreifuss muscular dystrophy/limb-girdle muscular dystrophy 1B. Neuromuscul. Disord. 19 (2008) 29–36.

    Article  PubMed  Google Scholar 

  86. Meshorer, E. and Gruenbaum, Y. Gone with the Wnt/Notch: stem cells in laminopathies, progeria, and aging. J. Cell Biol. 181 (2008) 9–13.

    Article  CAS  PubMed  Google Scholar 

  87. Jones, D.L. and Wagers, A.J. No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell. Biol. 9 (2008) 11–21.

    Article  CAS  PubMed  Google Scholar 

  88. Favreau, C., Higuet, D., Courvalin, J.C. and Buendia, B. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol. Cell. Biol. 24 (2004) 1481–1492.

    Article  CAS  PubMed  Google Scholar 

  89. Takai, H., Yamada, T., Tada, S. and Matsumaru, I. Successful surgical repair for Emery-Dreifuss muscular dystrophy valvular disease with longterm follow-up. Interac. Cardiovasc. Thorac. Surg. 10 (2010) 811–812.

    Article  Google Scholar 

  90. Dechat, T., Shimi, T., Adam, S.A., Rusinol, A.E., Andres, D.A., Spielmann, H.P., Sinensky, M.S. and Goldman, R.D. Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc. Natl. Acad. Sci. USA 104 (2007) 4955–4960.

    Article  CAS  PubMed  Google Scholar 

  91. Rodriguez, S., Coppedè, F., Sagelius, H. and Eriksson, M. Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging. Eur. J. Hum. Genet. 17 (2009) 928–937.

    Article  CAS  PubMed  Google Scholar 

  92. Goldman, R.D., Shumaker, D.K., Erdos, M.R., Eriksson, M., Goldman, A.E., Gordon, L.B., Gruenbaum, Y., Khuon, S., Mendez, M., Varga, R. and Collins, F.S. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA. 101 (2004) 8963–8968.

    Article  CAS  PubMed  Google Scholar 

  93. Mallampalli, M.P., Huyer, G., Bendale, P., Gelb, M.H. and Michaelis, S. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA 102 (2005) 14416–14421.

    Article  CAS  PubMed  Google Scholar 

  94. Toth, J.I., Yang, S.H., Qiao, X., Beigneux, A.P., Gelb, M.H., Moulson, C.L., Miner, J.H., Young, S.G. and Fong, L.G. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc. Natl. Acad. Sci. USA 102 (2005) 12873–12878.

    Article  CAS  PubMed  Google Scholar 

  95. Capell, B.C., Olive, M., Erdos, M.R., Cao, K., Faddah, D.A., Tavarez, U.L., Conneely, K.N., Qu, X., San, H., Ganesh, S.K., Chen, X., Avallone, H., Kolodgie, F.D., Virmani, R., Nabel, E.G. and Collins, F.S. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc. Natl. Acad. Sci. USA 105 (2008) 15902–15907.

    Article  CAS  PubMed  Google Scholar 

  96. Yang, S.H., Qiao, X., Fong, L.G. and Youn, S.G. Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation. Biochim. Biophys. Acta 1781 (2008) 36–39.

    CAS  PubMed  Google Scholar 

  97. Yang, S.H., Andres, D.A., Spielmann, H.P., Young, S.G. and Fong, L.G. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated. J. Clin. Invest. 118 (2008) 3291–3300.

    Article  CAS  PubMed  Google Scholar 

  98. Varela, I., Pereira, S., Ugalde, A.P., Navarro, C.L., Suárez, M.F., Cau, P., Cadiñanos, J., Osorio, F.G., Cobo, J., de Carlos, F., Lèvy, N., Freije, J.M.P. and López-Otín, C. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat. Med. 14 (2008) 767–772.

    Article  CAS  PubMed  Google Scholar 

  99. Kieran, M.W., Gordon, L. and Kleinman, M. New approaches to progeria. Pediatrics 120 (2007) 834–841.

    Article  PubMed  Google Scholar 

  100. Davies, B.S., Barnes, R.H., Tu, Y., Ren, S., Andres, D.A., Spielmann, H.P., Lammerding, J., Wang, Y., Young, S.G. and Fong, L.G. An accumulation of non-farnesylated pre-lamin A causes cardiomyopathy but not progeria. Hum. Mol. Genet. 19 (2010) 2682–2694.

    Article  CAS  PubMed  Google Scholar 

  101. Caron, M., Auclair, M., Donadille, B., Béréziat, V., Guerci, B., Laville, M., Narbonne, H., Bodemer, C., Lascols, O., Capeau, J. and Vigouroux, C. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with pre-lamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ. 14 (2007) 1759–1767.

    Article  CAS  PubMed  Google Scholar 

  102. Coffinier, C., Hudon, S.E., Farber, E.A., Chang, S.Y., Hrycyna, C.A., Young, S.G. and Fong, L.G. HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of pre-lamin A in cells. Proc. Natl. Acad. Sci. USA 104 (2007) 13432–13437.

    Article  CAS  PubMed  Google Scholar 

  103. Huang, S., Chen, L., Libina, N., Janes, J., Martin, G.M., Campisi, J. and Oshima, J. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference. Hum. Genet. (2005) 1–7.

  104. Fong, L.G., Ng, J.K., Lammerding, J., Vickers, T.A., Meta, M., Cote, N., Gavino, B., Qiao, X., Chang, S.Y., Young, S.R., Yang, S.H., Stewart, C.L., Lee, R.T., Bennett, C.F., Bergo, M.O. and Young, S.G. Pre-lamin A and lamin A appear to be dispensable in the nuclear lamina. J. Clin. Invest. 116 (2006) 743–752.

    Article  CAS  PubMed  Google Scholar 

  105. Fong, L.G., Vickers, T.A., Farber, E.A., Choi, C., Yun, U.J., Hu, Y., Yang, S.H., Coffinier, C., Lee, R., Yin, L., Davies, B.S., Andres, D.A., Spielmann, H.P., Bennett, C.F. and Young, S. Activating the synthesis of progerin, the mutant pre-lamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides. Hum. Mol. Genet. 18 (2009) 2462–2471.

    Article  CAS  PubMed  Google Scholar 

  106. Marji, J., O’Donoghue, S.I., McClintock, D., Satagopam, V.P., Schneider, R., Ratner, D., Worman, H., Gordon, L.B. and Djabali, K. Defective lamin A-Rb signaling in Hutchinson-Gilford Progeria Syndrome and reversal by farnesyltransferase inhibition. PLoS One 5 (2010) e11132.

  107. Scaffidi, P. and Misteli, T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat. Cell Biol. 10 (2008) 452–459.

    Article  CAS  PubMed  Google Scholar 

  108. Scaffidi, P. and Misteli, T. Lamin A-dependent nuclear defects in human aging. Science 312 (2006) 1059–1063.

    Article  CAS  PubMed  Google Scholar 

  109. Espada, J., Varela, I., Flores, I., Ugalde, A.P., Cadinanos, J., Pendas, A.M., Stewar, C.L., Tryggvason, K., Blasco, M.A., Freije, J.M. and Lopez-Otin, C. Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J. Cell Biol. 181 (2008) 27–35.

    Article  CAS  PubMed  Google Scholar 

  110. Hegele, R.A., Joy, T.R., Al-Attar, S.A. and Rutt, B.K. Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J. Lipid Res. 48 (2007) 1433–1444.

    Article  CAS  PubMed  Google Scholar 

  111. Tilgner, K., Wojciechowicz, K., Jahoda, C., Hutchison, C. and Markiewicz, E. Dynamic complexes of A-type lamins and emerin influence adipogenic capacity of the cell via nucleocytoplasmic distribution of ta-catenin. J. Cell Sci. 122 (2009) 401–413.

  112. Christodoulides, C., Lagathu, C., Sethi, J.K. and Vidal-Puig, A. Adipogenesis and WNT signalling. Trends Endocrinol. Metab. 20 (2009) 16–24.

    Article  CAS  PubMed  Google Scholar 

  113. Guillet-Deniau, I., Pichard, A.-L., Kone, A., Esnous, C., Nieruchalski, M., Girard, J. and Prip-Buus, C. Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway. J. Cell Sci. 117 (2004) 1937–1944.

    Article  CAS  PubMed  Google Scholar 

  114. Lloyd, D.J., Trembath, R.C. and Shackleton, S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum. Mol. Genet. 11 (2002) 769–777.

    Article  CAS  PubMed  Google Scholar 

  115. Javor, E.D., Cochran, E.K., Musso, C., Young, J.R., Depaoli, A.M. and Gorden, P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 54 (2005) 1994–2002.

    Article  CAS  PubMed  Google Scholar 

  116. Park, J.Y., Javor, E.D., Cochran, E.K., DePaoli, A.M. and Gorden, P. Longterm efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism 56 (2007) 508–516.

    Article  CAS  PubMed  Google Scholar 

  117. Maraldi, N.M., Capanni, C., Lattanzi, G., Camozzi, D., Facchini, A. and Manzoli, F.A. SREBP1 interaction with pre-lamin A forms: a pathogenic mechanism for lipodystrophic laminopathies. Adv. Enzyme Regul. 48 (2008) 209–223.

    Article  CAS  PubMed  Google Scholar 

  118. Broers, J.L., Ramaekers, F.C., Bonne, G., Yaou, R.B. and Hutchison, C.J. Nuclear lamins: laminopathies and their role in premature ageing. Physiol. Rev. 86 (2006) 967–1008.

    Article  CAS  PubMed  Google Scholar 

  119. Méjat, A.V., Decostre, J., Li, L., Renou, A., Kesari, D., Hantaï, C.L., Stewart, X., Xiao, E., Hoffman, G., Bonne, G. and Misteli, T. Lamin A/C — mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy. J. Cell Biol. 184 (2009) 31–44.

    Article  PubMed  CAS  Google Scholar 

  120. Bridger, J.M., Foeger, N., Kill, I.R. and Herrmann, H. The nuclear lamina. Both a structural framework and a platform for genome organization. FEBS J. 274 (2007) 1354–1361.

    Article  CAS  PubMed  Google Scholar 

  121. Wilson, K.L. and Foisner, R. Lamin-binding Proteins. Cold Spring Harb Perspect. Biol. 2 (2010) a000554.

  122. Rzepecki, R. and Fisher, P.A. In vivo phosphorylation of Drosophila melanogaster nuclear lamins during both interphase and mitosis. Cell. Mol. Biol. Lett. 7 (2002) 859–876.

    CAS  PubMed  Google Scholar 

  123. Zhang, Y.Q. and Sarge, K.D. Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies. J. Cell Biol. 182 (2008) 35–39.

    Article  CAS  PubMed  Google Scholar 

  124. Cenni, V., Bertacchini, J., Beretti, F., Lattanzi, G., Bavelloni, A., Riccio, M., Ruzzene, M., Marin, O., Arrigoni, G., Parnaik, V., Wehnert, M., Maraldi, N.M., de Pol, A., Cocco, L. and Marmiroli, S. Lamin A Ser404 is a nuclear target of Akt phosphorylation in C2C12 cells. J. Proteome Res. 7 (2008) 4727–4735.

    Article  CAS  PubMed  Google Scholar 

  125. Tifft, K.E., Bradbury, K.A. and Wilson, K.L. Tyrosine phosphorylation of nuclear-membrane protein emerin by Src, Abl and other kinases. J. Cell Sci. 122 (2009) 3780–3790.

    Article  CAS  PubMed  Google Scholar 

  126. Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., Stewart, C.L. and Burke, B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147 (1999) 913–920.

    Article  CAS  PubMed  Google Scholar 

  127. Leung, G.K., Schmidt, W.K., Bergo, M.O., Gavino, B., Wong, D.H., Tam, A., Ashby, M.N., Michaelis, S. and Young, S.G. Biochemical studies of Zmpste24-deficient mice. J. Biol. Chem. 276 (2001) 29051–29058.

    Article  CAS  PubMed  Google Scholar 

  128. Ozawa, R., Hayashi, Y.K., Ogawa, M., Kurokawa, R., Matsumoto, H., Noguchi, S., Nonaka, I. and Nishino, I. Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles. Am. J. Pathol. 186 (2006) 907–917.

    Article  CAS  Google Scholar 

  129. Arimura, T., Helbling-Leclerc, A., Massart, C., Varnous, S., Niel, F., Lacene, E., Fromes, Y., Toussaint, M., Mura, A.M., Keller, D.I., Amthor, H., Isnard, R., Malissen, M., Schwartz, K. and Bonne, G. Mouse model carrying H222P-LMNA mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum. Mol. Genet. 14 (2005) 155–169.

    Article  CAS  PubMed  Google Scholar 

  130. Mounkes, L.C., Kozlov, S.V., Rottman, J.N. and Stewart, C.L. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum. Mol. Genet. 14 (2006) 2167–2180.

    Article  CAS  Google Scholar 

  131. Wang, Y., Herron, A.J. and Worman, H.J. Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy. Hum. Mol. Genet. 15 (2006) 2479–2489.

    Article  CAS  PubMed  Google Scholar 

  132. Nikolova, V., Leimena, C., McMahon, A.C., Tan, J.C., Chandar, S., Jogia, D., Kesteven, S.H., Michalicek, J., Otway, R., Verheyen, F., Rainer, S., Stewart, C.L., Martin, D., Feneley, M.P. and Fatkin, D. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/Cdeficient mice. J. Clin. Invest. 113 (2004) 357–369.

    CAS  PubMed  Google Scholar 

  133. Alsheimer, M., Liebe, B., Sewell, L., Stewart, C.L., Scherthan, H. and Benavente, R. Disruption of spermatogenesis in mice lacking A-type lamins. J. Cell Sci. 117 (2004) 1173–1178.

    Article  CAS  PubMed  Google Scholar 

  134. Hale, J.S., Frock, R.L., Mamman, S.A., Fink, P.J. and Kennedy, B.K. Cellextrinsic defective lymphocyte development in Lmna −/− mice. PLoS One 5 (2010) e10127.

    Article  PubMed  CAS  Google Scholar 

  135. Bergo, M.O. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a pre-lamin A processing defect. Proc. Natl. Acad. Sci. USA 99 (2002) 13049–13054.

    Article  CAS  PubMed  Google Scholar 

  136. Anjos-Afonso, F., Siapati, E.K. and Bonnet, D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J. Cell Sci. 117 (2004) 5655–5664.

    Article  CAS  PubMed  Google Scholar 

  137. Cousins, J.C., Woodward, K.J., Gross, J.G., Partridge, T.A. and Morgan, J.E. Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal. J. Cell Sci. 117 (2004) 3259–3269.

    Article  CAS  PubMed  Google Scholar 

  138. D`Ippolito, G., Diabira, S., Howard, G.A., Menei, P., Roos, B.A. and Schiller, P.C. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci. 117 (2004) 2971–2981.

    Article  CAS  Google Scholar 

  139. Mazhari, R. and Hare, J.M. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat. Clin. Pract. Cardiovasc. Med. 4 (2007) S21–26.

    Article  PubMed  Google Scholar 

  140. Dwyer, R.M., Khan, S., Barry, F.P., O’Brien, T. and Kerin, M.J. Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Res. Ther. 1 (2010) 25.

    Article  PubMed  CAS  Google Scholar 

  141. Pistoia, V. and Raffaghello, L. Potential of mesenchymal stem cells for the therapy of autoimmune diseases. Expert Rev. Clin. Immunol. 6 (2010) 211–218.

    Article  CAS  PubMed  Google Scholar 

  142. Griffin, M., Greiser, U., Barry, F., O’Brien, T. and Ritter, T. Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease. Discov. Med. 9 (2010) 219–223.

    PubMed  Google Scholar 

  143. Epting, C.L., Lopez, J.E., Shen, X., Liu, L., Bristow, J. and Bernstein, H.S. Stem cell antigen-1 is necessary for cell-cycle withdrawal and myoblast differentiation in C2C12 cells. J. Cell Sci. 117 (2004) 6185–6195.

    Article  CAS  PubMed  Google Scholar 

  144. Rivier, F., Alkan, O., Flint, A.F., Muskiewicz, K., Allen, P.D., Leboulch, P. and Gussoni, E. Role of bone marrow cell trafficking in replenishing skeletal muscle SP and MP cell populations. J. Cell Sci. 117 (2004) 1979–1988.

    Article  CAS  PubMed  Google Scholar 

  145. Banasik, M.B. and McCray, P.B.J. Integrase-defective lentiviral vectors: progress and applications. Gene Ther. 17 (2010) 150–157.

    Article  CAS  PubMed  Google Scholar 

  146. Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C.C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., Mahlaoui, N., Kiermer, V., Mittelstaedt, D., Bellesme, C., Lahlou, N., Lefrère, F., Blanche, S., Audit, M., Payen, E., Leboulch, P., l’Homme, B., Bougnères, P., Von Kalle, C., Fischer, A., Cavazzana-Calvo, M. and Aubourg, P. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326 (2009) 818–823.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Nuclear Proteins, Faculty of Biotechnology, University of Wrocław, ul. Przybyszewskiego 63/77, 51-148, Wroclaw, Poland

    Magdalena Zaremba-Czogalla, Magda Dubińska-Magiera & Ryszard Rzepecki

Authors
  1. Magdalena Zaremba-Czogalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magda Dubińska-Magiera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ryszard Rzepecki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryszard Rzepecki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zaremba-Czogalla, M., Dubińska-Magiera, M. & Rzepecki, R. Laminopathies: The molecular background of the disease and the prospects for its treatment. Cell Mol Biol Lett 16, 114–148 (2011). https://doi.org/10.2478/s11658-010-0038-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11658-010-0038-9

Key words

Cellular & Molecular Biology Letters

ISSN: 1689-1392

Contact us